Page last updated: 2024-08-17

medroxyprogesterone acetate and Adverse Drug Event

medroxyprogesterone acetate has been researched along with Adverse Drug Event in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (66.67)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Forcier, M; Jain, J; Kwan, D	1
Brito, MB; Ferriani, RA; Quintana, SM; Silva de Sá, MF; Vieira, CS; Yazlle, ME	1
Jassem, J; Senkus-Konefka, E	1
Helmond, FA; Landgren, BM; Langer, RD; Rymer, J	1

Trials

2 trial(s) available for medroxyprogesterone acetate and Adverse Drug Event

Article	Year
Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception, 2009, Volume: 80, Issue:6 Topics: Adolescent; Adult; Analysis of Variance; Blood Cell Count; Body Mass Index; Body Weight; C-Reactive Protein; Chi-Square Distribution; Cholesterol; Contraceptive Agents, Female; Cytokines; Desogestrel; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant, Newborn; Lactation; Medroxyprogesterone Acetate; Patient Selection; Pilot Projects; Statistics, Nonparametric; Waist Circumference	2009
Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study. American journal of obstetrics and gynecology, 2006, Volume: 195, Issue:5 Topics: Aged; Biopsy; Contraceptive Agents, Female; Double-Blind Method; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Endometrium; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Osteoporosis; Ultrasonography; Uterine Hemorrhage	2006

Article

Year

Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study.

Contraception, 2009, Volume: 80, Issue:6

Topics: Adolescent; Adult; Analysis of Variance; Blood Cell Count; Body Mass Index; Body Weight; C-Reactive Protein; Chi-Square Distribution; Cholesterol; Contraceptive Agents, Female; Cytokines; Desogestrel; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant, Newborn; Lactation; Medroxyprogesterone Acetate; Patient Selection; Pilot Projects; Statistics, Nonparametric; Waist Circumference

2009

Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.

American journal of obstetrics and gynecology, 2006, Volume: 195, Issue:5

Topics: Aged; Biopsy; Contraceptive Agents, Female; Double-Blind Method; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Endometrium; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Osteoporosis; Ultrasonography; Uterine Hemorrhage

2006

Other Studies

4 other study(ies) available for medroxyprogesterone acetate and Adverse Drug Event

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Medroxyprogesterone Acetate in Gender-Affirming Therapy for Transwomen: Results From a Retrospective Study. The Journal of clinical endocrinology and metabolism, 2019, 11-01, Volume: 104, Issue:11 Topics: Adult; Breast; Drug-Related Side Effects and Adverse Reactions; Estradiol; Estrogens; Female; Hair; Humans; Incidence; Male; Medroxyprogesterone Acetate; Middle Aged; Mineralocorticoid Receptor Antagonists; Retrospective Studies; Self Report; Spironolactone; Testosterone; Transgender Persons; Treatment Outcome	2019
Report on the 4th European Breast Cancer Conference, Hamburg, Germany, 16-20 March 2004. Breast cancer research : BCR, 2004, Volume: 6, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aromatase Inhibitors; Biotransformation; Breast Neoplasms; Cardiovascular Diseases; Chemotherapy, Adjuvant; Clinical Trials as Topic; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Gene Expression Profiling; Genes, p53; Humans; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Paclitaxel; Pharmacogenetics; Tamoxifen; Trastuzumab	2004